Your browser doesn't support javascript.
loading
Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice.
Sun, Shihui; He, Lei; Zhao, Zhongpeng; Gu, Hongjing; Fang, Xin; Wang, Tiecheng; Yang, Xiaolan; Chen, Shaolong; Deng, Yongqiang; Li, Jiangfan; Zhao, Jian; Li, Liang; Li, Xinwang; He, Peng; Li, Ge; Li, Hao; Zhao, Yuee; Gao, Chunrun; Lang, Xiaoling; Wang, Xin; Fei, Guoqiang; Li, Yan; Geng, Shusheng; Gao, Yuwei; Wei, Wenjin; Hu, Zhongyu; Han, Gencheng; Sun, Yansong.
  • Sun S; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • He L; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Zhao Z; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Gu H; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Fang X; National Institutes for Food and Drug Control, Beijing, China.
  • Wang T; Institute of Military Veterinary, Academic of Military Medical Sciences, Changchun, China.
  • Yang X; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Chen S; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Deng Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Li J; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Zhao J; JOINN Biologics, Beijing, China.
  • Li L; Institute of Military Veterinary, Academic of Military Medical Sciences, Changchun, China.
  • Li X; ZHONGYIANKE Biotech Co., LTD, Tianjin, China.
  • He P; National Institutes for Food and Drug Control, Beijing, China.
  • Li G; Beijing Institute of Basic Medical Sciences, Beijing, China.
  • Li H; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Zhao Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
  • Gao C; ZHONGYIANKE Biotech Co., LTD, Tianjin, China.
  • Lang X; JOINN Biologics, Beijing, China.
  • Wang X; ZHONGYIANKE Biotech Co., LTD, Tianjin, China.
  • Fei G; ZHONGYIANKE Biotech Co., LTD, Tianjin, China.
  • Li Y; Beijing Institute of Basic Medical Sciences, Beijing, China.
  • Geng S; JOINN Biologics, Beijing, China.
  • Gao Y; Institute of Military Veterinary, Academic of Military Medical Sciences, Changchun, China. gaoyuwei@gmail.com.
  • Wei W; ZHONGYIANKE Biotech Co., LTD, Tianjin, China. weiwenjin66@126.com.
  • Hu Z; National Institutes for Food and Drug Control, Beijing, China. huzy67@163.com.
  • Han G; Beijing Institute of Basic Medical Sciences, Beijing, China. genchenghan@163.com.
  • Sun Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China. yansongsunamms@126.com.
Cell Mol Immunol ; 18(4): 1070-1073, 2021 04.
Article en En | MEDLINE | ID: mdl-33731916
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article